ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1258 • 2019 ACR/ARP Annual Meeting

    Effects of Intravenous Golimumab, an Anti-TNFα Monoclonal Antibody, on Health-Related Quality of Life in Patients with Ankylosing Spondylitis: 1-Year Results of a Phase III Trial

    John Reveille1, Atul Deodhar 2, Diane Harrison 3, Elizabeth Hsia 4, Eric K H Chan 3, Shelly Kafka 5, Kim Hung Lo 3, Lilianne Kim 3 and Chenglong Han 3, 1University of Texas McGovern Medical School, Houston, 2Oregon Health & Science University, Portland, OR, 3Janssen Research & Development, LLC, Spring House, PA, 4Janssen Research & Development, LLC/University of Pennsylvania, Spring House/Philadelphia, PA, 5Janssen Scientific Affairs, LLC, Horsham, PA

    Background/Purpose: In patients with ankylosing spondylitis (AS), IV administration of the anti-TNFa antibody golimumab (GLM-IV) resulted in improvements in composite measures of various aspects of…
  • Abstract Number: 1259 • 2019 ACR/ARP Annual Meeting

    Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO): A Case Series

    Devanshu Verma1, Samir Shah 2 and Arundathi Jayatilleke 3, 1Drexel University, Philadelphia, 2Thomas Jefferson University, Philadelphia, 3Drexel, Philadelphia, PA

    Background/Purpose: SAPHO is a chronic multisystemic illness with predominantly skin and joint manifestations. Disease presentation is heterogenous; proposed diagnostic criteria include chronic multifocal aseptic osteomyelitis…
  • Abstract Number: 1260 • 2019 ACR/ARP Annual Meeting

    The Study of Peripheral Blood Lymphocyte Subsets and CD4+T Subsets in Recurrent Polychondritis

    Fang Yuan Hu1, Ning Yan 1, Jie Liang 1, Xiao feng li 2 and Cai-hong Wang 3, 1The second hospital of shanxi medical university, Taiyuan, China (People's Republic), 2The Second hospital of Shanxi Medical University, Taiyuan, China (People's Republic), 3The Second Hospital of Shanxi Medical University, Tai Yuan, China (People's Republic)

    Background/Purpose: Relapsing polychondritis (RP) is an uncommon systemic connective tissue disorder characterized by recurrent and episodic inflammation of cartilaginous tissues, such as ear, nose, joint,…
  • Abstract Number: 1261 • 2019 ACR/ARP Annual Meeting

    The Time Lag – the Race in Diagnosis and Management of Hemophagocytic Lymphohistiocytosis

    Sneha Patel1, Bibi Ayesha 2, Anna Broder 3, Inessa Gendlina 2, Irina Murakhovskaya 4, Manish Ramesh 2, Yevgeniy Balagula 2 and Anand Kumthekar 2, 1Montefiore Hospital/Albert Einstein College of Medicine, Bronx, NY, 2Montefiore Hospital/Albert Einstein College of Medicine, Bronx, 3Rheumatology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, 4Hematologist, Bronx

    Background/Purpose: Hemophagocytic lymphohistiocytosis (HLH) is an aggressive and life-threatening syndrome of disordered immune activation marked by excessive inflammation. Immunosuppression remains the mainstay of therapy after…
  • Abstract Number: 1262 • 2019 ACR/ARP Annual Meeting

    Clinical Features of Elderly-onset Adult Still’s Disease

    Sayaka Takenaka1, Takehisa Ogura 1, Yuto Takakura 1, Takaharu Katagiri 1, Yuki Inoue 1, Ayako Hirata 1 and Hideto Kameda 2, 1Division of Rheumatology, Department of Internal medicine Toho University Ohashi Medical Center, Tokyo, Japan, 2Toho University, Tokyo, Japan, Tokyo, Japan

    Background/Purpose: The peak age at the onset of adult Still's disease (ASD) has been between 20 and 35 years old. However, the proportion of elderly-onset…
  • Abstract Number: 1263 • 2019 ACR/ARP Annual Meeting

    The Prevalence and Patterns of Celiac Disease Associated Arthropathy and Coexistence of Celiac Disease with Rheumatic Disorders in a Single Tertiary Medical Center

    Anita Moudgal1, Pooja Bhadbhade 1, Ammar Haikal 1 and Mehrdad Maz 1, 1The University of Kansas Medical Center, Kansas City, KS

    Background/Purpose: Celiac disease (CD) is a gluten-sensitive enteropathy that develops in genetically predisposed individuals. Arthropathy has been reported as an extra-intestinal manifestation of CD. The…
  • Abstract Number: 1264 • 2019 ACR/ARP Annual Meeting

    Quality of Life in Patients with SAPHO Syndrome: A Single-center Survey of 588 Patients

    Zhaohui Li 1, Chen Li2, Yihan Cao 3, Yirong Xiang 1, Yueting Li 4 and Wen Zhang 5, 1Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, Beijing, Beijing, China (People's Republic), 2Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, Beijing, Beijing, China (People's Republic), 3Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, Beijing, China (People's Republic), 4Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College; The Ministry of Education Key Laboratory, Beijing, China, Beijing, China (People's Republic), 5Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China (People's Republic)

    Background/Purpose: Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare autoimmune disease with heterogeneous presentation and severe disease burden. Factors influencing the quality…
  • Abstract Number: 1265 • 2019 ACR/ARP Annual Meeting

    Mandibular Involvement in SAPHO Syndrome: A Single-center Retrospective Study of 26 Patients

    Yueting Li1, Chen Li 2, Mu Wang 3, Yihan Cao 4, Yirong Xiang 5, Zhaohui Li 6, Wen Zhang 7 and Jizhi zhao 8, 1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College; The Ministry of Education Key Laboratory, Beijing, China, Beijing, China (People's Republic), 2Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, Beijing, Beijing, China (People's Republic), 3Department of Stomatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Beijing, China (People's Republic), 4Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, Beijing, China (People's Republic), 5Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, Beijing, Beijing, China (People's Republic), 6Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College. No.1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing, 100730, China, Beijing, China (People's Republic), 7Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China (People's Republic), 8Department of Stomatology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College. No.1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing, 100730, China, Beijing, China (People's Republic)

    Background/Purpose: Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a heterogeneous chronic inflammatory disease of unknown etiology. Mandibular involvement appeared in approximately 10% of…
  • Abstract Number: 1266 • 2019 ACR/ARP Annual Meeting

    AGBL3 as a Novel Gene Associated with Hereditary Hypocomplementemic Urticarial Vasculitis and Favorable Response to Rituximab

    Ahmet Gul1, Nesllihan Abaci 2 and Sema Sirma-Ekmekci 2, 1Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, Istanbul, Turkey, 2Department of Genetics, Istanbul University Institute for Experimental Medical Research, Istanbul, Turkey, Istanbul, Turkey

    Background/Purpose: Urticarial skin lesions are well-known features of autoinflammatory disorders associated with NLRP3 and NLRP12 variants. However hereditary forms of hypocomplementemic urticarial vasculitis (HUV) with…
  • Abstract Number: 1267 • 2019 ACR/ARP Annual Meeting

    Epidemology, Clinical Features and Relationship to Biological Therapy of Uveitis in Axial Spondyloarthritis: Single Center University Study

    Iñigo Gonzalez-Mazon1, Lara Sanchez-Bilbao 2, Javier Rueda-Gotor 3, DAVID MARTINEZ-LOPEZ 4, DIANA PRIETO- PENA 1, Mónica Calderón-Goercke 5, Jose Luis Martín-Varillas 2, Belén Atienza-Mateo 2, Miguel A Gonzalez-Gay 2 and Ricardo Blanco 2, 1Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain, 2Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Spain, 3Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain, Santander, Spain, 4Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 5Hospital Marqués de Valdecilla, Santander, Cantabria, Spain

    Background/Purpose: Uveitis is one of the most frequent extra articular manifestation of spondyloarthritis (SpA). Biological therapy, especially monoclonal TNF inhibitors, are useful to prevent and…
  • Abstract Number: 1268 • 2019 ACR/ARP Annual Meeting

    Different Colchicine Preparations for Familial Mediterranean Fever: Are They the Same?

    Hakan Emmungil1, Ufuk İlgen 1, Sezin Turan 1, Samet Yaman 2 and Orhan Küçükşahin 3, 1Trakya University, Edirne, Turkey, 2Yıldırım Beyazıt University, Ankara, Turkey, 3Liv Hospital, Ankara, Turkey

    Background/Purpose: Colchicine is the mainstay of treatment for prevention of attacks and associated amyloidosis in Familial Mediterranean Fever (FMF). Two approved colchicine preparations are currently…
  • Abstract Number: 1269 • 2019 ACR/ARP Annual Meeting

    Effective Treatment of TNFα Inhibitors in Chinese Patients with Blau Syndrome

    Jing Chen 1, Yi Luo 1, Mengzhu Zhao 1, Di Wu 1, Yunjiao Yang 2, Wen Zhang 3 and Min Shen1, 1Peking Union Medical College Hospital, Beijing, Beijing, China (People's Republic), 2Peking Union Medical College Hospital, Beijing, China (People's Republic), 3Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China (People's Republic)

    Background/Purpose: Blau syndrome (BS) is a rare dominantly inherited autoinflammatory disorder associated with mutations in the NOD2 gene. BS is mainly seen in Caucasian patients.…
  • Abstract Number: 1270 • 2019 ACR/ARP Annual Meeting

    Effectiveness and Safety of Off-label Use of Tocilizumab in Refractory Autoimmune Diseases: A Multicenter Study

    Martin Michaud1, Thomas Sene 2, Pascal Chazerain 2, Geoffrey Urbanski 3, Frederique Retornaz 4, Boris Bienvenu 5, Laurent Chiche 4, Florian Catros 6, Laurent Sailler 7, Laurent Alric 8, Jean Thomas Giraud 9, Léo Caudrelier 10, Slim Lassoued 10, Sophie Ancellin 6, Olivier Lidove 2 and Francis Gaches 6, 1Joseph Ducuing Hospital, Toulouse, France, 2Hôpital Croix Saint Simon, Paris, France, 3CHU Angers, Angers, France, 4Hôpital Européen, Marseille, France, 5Hôpital Saint Joseph, Marseille, France, 6Hôpital Joseph Ducuing, Toulouse, France, 7University Hospital of Toulouse, Toulouse, France, 8CHU Toulouse, Toulouse, France, 9Hôpital de Tarbes, Tarbes, France, 10Hôpital de Cahors, Cahors, France

    Background/Purpose: There is increasing evidence of Tocilizumab (TCZ) efficacy in refractory auto-immune diseases. The present study aimed at evaluating the real-world experience of using TCZ…
  • Abstract Number: 1271 • 2019 ACR/ARP Annual Meeting

    Adult-Onset Still’s Disease Prognosis Score: Clinical Patterns, Complications and Biologic Treatment

    Ivette Casafont-Solé1, Susana Holgado 1, Javier Narváez 2, Maribel Mora 3, Josep Roca 4, Anahy Brandy-Garcia 1, Lourdes Mateo 1, Melania Martínez-Morillo 1, Laia Gifre 1, Maria Aparicio-Espinar 1, Águeda Prior-Español 1, Anne Riveros-Frutos 1, Clara Sangüesa 1, Jordi Camins-Fàbregas 1, Annika Nack 1, Joan Miquel Nolla 3 and Alejandro Olivé-Marqués 4, 1Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 2Rheumatology Department, Hospital Universitario de Bellvitge, Barcelona, Spain, Barcelona, Catalonia, Spain, 3Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain, 4Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain

    Background/Purpose: Adult-onset Still’s disease (AOSD) is a low prevalent disease with an unpredictable clinical course and variable prognosis. Sometimes, it requires biologic treatment in early…
  • Abstract Number: 1272 • 2019 ACR/ARP Annual Meeting

    Biological Therapy in Non Ischaemic Optic Neuritis Associated to Immune-mediated Inflammatory Diseases: Multicenter Study

    DIANA PRIETO- PENA1, Vanesa Calvo Río 2, Mónica Calderón-Goercke 3, Olga Maíz Alonso 4, A Blanco 5, Javier Narváez 6, Santos Castañeda 7, E Vicente 8, Susana Romero-Yuste 9, Rosalia Demetrio 10, Ana Urriticoechea Arana 11, JL García Serrano 12, JL Callejas Rubio 12, Norberto Ortego Centeno 12, Julio Sanchez 13, Lucia Cristina Dominguez Casas 10, Lara Sanchez-Bilbao 2, Iñigo Gonzalez-Mazon 1, Miguel Angel González-Gay 14 and Ricardo Blanco 2, 1Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain, 2Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Spain, 3Hospital Marqués de Valdecilla, Santander, Cantabria, Spain, 4H. Donostia, San Sebastián, Spain, 5H. Donostia, Donostia, Spain, 6Rheumatology Department, Hospital Universitario de Bellvitge, Barcelona, Spain, Barcelona, Catalonia, Spain, 7Rheumatology Department, Hospital Universitario de la Princesa, IIS-Princesa, Madrid, Spain, Madrid, Spain, 8H. Princesa, Madrid, Spain, 9Complejo Hospitalario Universitario Pontevedra, Pontevedra, Galicia, Spain, 10Hospital Universitario Marqués de Valdecilla, Santander, Spain, 11H. Can Misses, Ibiza, Spain, 12H. San Cecilio, Granada, Spain, 13H. 12 de Octubre, Madrid, Spain, 14Universidad de Cantabria and IDIVAL, Hospital Universitario Marqués de Valdecilla, Santander, Spain

    Background/Purpose: Non ischaemic optic neuritis (NION) is a severe inflammation of the optic nerve that may lead to blindness. It can be primary or associated…
  • « Previous Page
  • 1
  • …
  • 1022
  • 1023
  • 1024
  • 1025
  • 1026
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology